Three drug reviews: one reformulated and one new antifungal agent and optimal dosing of the anticonvulsant gabapentin.
Walson
Philip D
PD
D000085:Acetates / Q000008:administration & dosage* / Q000627:therapeutic use; D000588:Amines; D000666:Amphotericin B / Q000008:administration & dosage* / Q000627:therapeutic use; D000927:Anticonvulsants / Q000008:administration & dosage* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D003509:Cyclohexanecarboxylic Acids; D004305:Dose-Response Relationship, Drug; D000077206:Gabapentin; D006801:Humans; D011743:Pyrimidines / Q000008:administration & dosage* / Q000627:therapeutic use; D014230:Triazoles / Q000008:administration & dosage* / Q000627:therapeutic use; D065819:Voriconazole; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D000935:Antifungal Agents; D003509:Cyclohexanecarboxylic Acids; D011743:Pyrimidines; D014230:Triazoles; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D000666:Amphotericin B; D065819:Voriconazole